## 

## 

## 

## 

## 



## 

## 

## 



## 

## 



## 

## 

## 




## 

|||||||2022|2021|
|---|---|---|---|---|---|---|---|
|||||Unrestricted|Restricted|Total|Total|
|||||fund|fund|funds|funds|
||||Notes|6|f||f|
|INCOME|AND ENDOWMENTS FROM|||||||
|Donations|and legacies|||383||383||
|Charitable|activities||3|||||
|To advance|the science|and art ofgynaecological||||||
|oncology for the benefit of the public||||316,542||316,542|218,991|
|Investment|income|||189||189|14|
|Other income|||||||553|
|Total||||317,114||317,114|219,558|
|EXPENDITURE ON||||||||
|Charitable|activities||4|||||
|Toadvance|the science|and art ofgynaecological||||||
|oncology for the benefit ofthe public||||250,680||250,680|88,013|
|NET INCOME||||66,434||66,434|131,545|
|RECONCILIATION||OFFUNDS||||||
|Total funds|brought<br>forward|||573,011||573,0]I|441,466|
|TOTAL FUNDS CARRIED FORWARD||||639,445||639,445|573,011|





## 

|||||2022|2021|
|---|---|---|---|---|---|
|||Unrestricted|Restricted|Total|Total|
|||fund|fimd|tbnds|funds|
||Notes||6|||
|CURRENT ASSETS||||||
|Debtors||85,306||85406|107,379|
|Cash at bank||566,114||566,114|476,082|
|||651,420||651,420|583,461|
|CREDITORS||||||
|Amounts<br>falling due within one year|10|(11&975)||(11&975)|(10,450)|
|NET CURRENT ASSETS||639&445||639&445|573,011|
|TOTAL ASSETSLESSCURRENT||||||
|LIABILITIES||639,445||639&445|573,011|
|NET ASSETS||639,445||639,445|573,011|
|FUNDS||||||
|Unrestricted<br>funds||||639&445|573,011|
|TOTALFUNDS||||639,445|573,011|





## 

## 

## 

## 

## 

## 

## 

## 

## 




## 

||INCOME|FR|OM CH|ARITABLE ACTIVIT|IES|||
|---|---|---|---|---|---|---|---|
|||||||2022|2021|
|||||Activity||||
|||||To advance the|science and art of|||
|||||gynaecological|oncology for the benefit of|||
||Sponsorships|||the public||120,500|88,400|
|||||To advance the|science and art of|||
|||||gynaecological|oncology for the benefit of|||
||Delegate fees|||the public||143,030|81,285|
|||||To advance the|science and art of|||
|||||gynaecological|oncology for the benefit of|||
||Subscriptions|||the public||53,012|49,306|
|||||||316,542|218,991|
|4.|CHARITABLE ACTIVITIES COSTS|||||||
|||||||Support||
||||||Direct|costs (see||
||||||Costs|note 5)|Totals|
||||||8|||
||To advance|the|science|and art of||||
||gynaecological||oncology for the benefit|||||
||ofthe public||||222,943|27,737|250,680|
|5.|SUPPORT|COSTS||||||
|||||||Governance||
||||||Management|costs|Totals|
||||||||f|
||To advance the||science|and art of||||
||gynaecological||oncology for the benefit of|||||
||the public||||23,199|4,538|27,737|
||INDEPENDENT EXAMINER'S FEES|||||||
|||||||2022f|2021<br>6|
||Independent|examiner's||fees||2,200|2,079|





## 

||Trustees'<br>expenses|||||
|---|---|---|---|---|---|
|||||2022|2021|
||Trustees' expenses|||2,33$||
|$.|COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES|||||
||||Unrestricted|Restricted|Total|
||||fund|fund|funds|
||||f||K|
||INCOME AND ENDOWMENTS FROM|||||
||Charitable<br>activities|||||
||To advance<br>the science|and srt of||||
||gynaecological<br>oncology for the benefit ofthe|||||
||public||218,991||218,991|
||Investment<br>income||14||14|
||Other income||553||553|
||Total||219,558||219,558|
||EXPENDITURE ON|||||
||Charitable<br>activities|||||
||To advance the science|and art of||||
||gynaecologicsl<br>oncology for the benefit ofthe|||||
||public||88,013||88,013|
||NET INCOME||131,545||131,545|
||RECONCILIATION|OF FUNDS||||
||Total funds brought<br>forward||441,466||441,466|
||TOTAL FUNDS CARRIED FORWARD||573,011||573,011|





|9.|DEBTORS:|DEBTORS:|AMOUNTS FALLING DUE WITHIN ONE YEAR|AMOUNTS FALLING DUE WITHIN ONE YEAR|AMOUNTS FALLING DUE WITHIN ONE YEAR||||
|---|---|---|---|---|---|---|---|---|
||||||||2022|2021|
||Other debtors||||||61,308|105,032|
||VAT||||||8,570||
||Prepayments||||||15,428|2,347|
||||||||85@06|107,379|
|10.|CREDITORS:|||AMOUNTS FALLING DUE WITHIN ONE YEAR|||||
||||||||2022|2021f|
||VAT|||||||7,260|
||Other creditors||||||7,276|1,191|
||Accruals|and|deferred income||||2&500||
||Accrued|expenses|||||2,199|1,999|
||||||||11)975|10,450|
|11.|MOVEMENT|||IN FUNDS|||||
||||||||Net||
||||||||movement|At|
||||||At|1.1.22|in funds|31.12.22|
||Unrestricted||funds||||||
||General|fund|||573,011||66,434|639&445|
||TOTAL|FUNDS|||573,011||66)434|639,445|
||Net movement||in funds, included||in the above are as follows:||||
||||||Incoming||Resources|Movement|
||||||resources||expended|in funds|
|||||||f.|||
||Unrestricted||funds||||||
||General|fund|||317,114||(250,680)|66,434|
||TOTAL|FUNDS|||317,114||(250,680)|66,434|





## 

## 

## 

||||Net||
|---|---|---|---|---|
||||movement|At|
|||At 1.1.21|in funds|31.12.21|
|Unrestricted|funds||||
|General fund||441,466|131,545|573,011|
|TOTALFUNDS||441,466|131,545|573,011|



|||Incoming|Resources|Movement|
|---|---|---|---|---|
|||resources|expended|in funds|
|||f.||f|
|Unrestricted|funds||||
|General fund||219,558|(88,013)|131,545|
|TOTALFUNDS||219,558|(88,013)|131,545|



|||||Net||
|---|---|---|---|---|---|
|||||movement|At|
||||At 1.1.21|in funds|31.12.22|
|||||f,||
|Unrestricted||funds||||
|General|fund||44],466|197,979|639,445|
|TOTAL|FUNDS||441,466|197,979|639,445|



|||Incoming|Resources|Movement|
|---|---|---|---|---|
|||resources<br>f|expended|in funds<br>f.|
|Unrestricted|funds||||
|General fund||536,672|(338,693)|197,979|
|TOTAL FUNDS||536,672|(338,693)|197,979|





## 

##